EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
Go back to EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies| (NASDAQ: EYEG) | Delayed: 34.52 -0.13 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.65 | 52 Week High | $5.09 | |||
| Open | $34.53 | 52 Week Low | $1.11 | |||
| Day High | $34.54 | P/E | N/A | |||
| Day Low | $34.52 | EPS | $0.00 | |||
| Volume | 2,108 | |||||

